Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Woolley

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?Amanda E Downey, Ellen R Bradley, Anna S Lerche, et al.
Psychiatry Research|January 17, 2025
A systematic review of participant diversity in psychedelic-assisted psychotherapy trialsStephanie L Haft, Amanda E Downey, Marissa Raymond-Flesch, et al.
Neuroscience and Biobehavioral Reviews|October 15, 2025
The allostatic triage model of psychopathology (ATP Model): How reallocation of brain energetic resources under stress elicits psychiatric symptomsD Parker Kelley, S Parker Singleton, Katy Venable, et al.
Eclinicalmedicine|November 5, 2020
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyBrian T Anderson, Alicia Danforth, Prof Robert Daroff, et al.
Contemporary Clinical Trials|June 21, 2020
Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trialJulianne C Flanagan, Jennifer M Mitchell, Nathaniel L Baker, et al.
Cell Transplantation|July 11, 2006
Towards the development of a pediatric ventricular assist deviceHarvey S Borovetz, Stephen Badylak, J Robert Boston, et al.
JAMA|August 31, 2023
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical TrialCharles L Raison, Gerard Sanacora, Joshua Woolley, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?Amanda E Downey, Ellen R Bradley, Anna S Lerche, et al.
Psychiatry Research|January 17, 2025
A systematic review of participant diversity in psychedelic-assisted psychotherapy trialsStephanie L Haft, Amanda E Downey, Marissa Raymond-Flesch, et al.
Neuroscience and Biobehavioral Reviews|October 15, 2025
The allostatic triage model of psychopathology (ATP Model): How reallocation of brain energetic resources under stress elicits psychiatric symptomsD Parker Kelley, S Parker Singleton, Katy Venable, et al.
Eclinicalmedicine|November 5, 2020
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyBrian T Anderson, Alicia Danforth, Prof Robert Daroff, et al.
Contemporary Clinical Trials|June 21, 2020
Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trialJulianne C Flanagan, Jennifer M Mitchell, Nathaniel L Baker, et al.
Cell Transplantation|July 11, 2006
Towards the development of a pediatric ventricular assist deviceHarvey S Borovetz, Stephen Badylak, J Robert Boston, et al.
JAMA|August 31, 2023
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical TrialCharles L Raison, Gerard Sanacora, Joshua Woolley, et al.
Pageof 2